Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
Holding OPRX?
Track your performance easily
OPRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.78 - $16.65
Previous CloseN/A
Volume200.46K
Average Volume (3M)252.50K
Market Cap
$100.03M
Enterprise Value$161.05M
Total Cash (Recent Filing)$7.03M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.03
Next Earnings
Feb 26, 2025EPS Estimate
0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.32
Shares Outstanding18,420,906
10 Day Avg. Volume142,223
30 Day Avg. Volume252,497
Standard Deviation0.20
R-Squared0.13
Alpha-0.00832
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.13
Price to Cash Flow (P/CF)14.00
P/FCF Ratio16.30
Enterprise Value/Market Cap1.61
Enterprise Value/Revenue1.83
Enterprise Value/Gross Profit3.75
Enterprise Value/Ebitda-6.86
Forecast
1Y Price Target
$9.06Price Target Upside60.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
OptimizeRx News
PremiumCompany Announcements
OptimizeRx CEO William Febbo Resigns, Leadership Transition Planned
Bulls Say, Bears Say
Bulls Say
Business GrowthManagement sees solid growth opportunities in the DAAP space, experiencing good traction during the Q4 RFP season, which suggests promising future expansion.
Client RevenueOne client is expected to generate $15M of in-year revenue, with four clients expected to generate over $10M of revenue in 2025, showcasing strong client relationships and revenue potential.
Financial PerformanceThe company expects its 2024 numbers to be at the higher end of the guidance ranges for revenue and AEBITDA, indicating robust financial health.
Bears Say
Earnings And GuidanceThe company lowered its 2024 revenue guide of at least $100M and AEBITDA of at least $11M to ranges of $88M-$92M and $8M-$10M.
Financial PerformanceRevenue came in roughly $3.7M short of the $25.0M consensus, mainly due to a shortfall in the Medicx business.
Management And LeadershipThe news of CEO Will Febbo's resignation was unexpected, as it came shortly after he purchased shares and right before a holiday.
---
Ownership Overview
14.68% Insiders
14.07% Mutual Funds
0.45% Other Institutional Investors
61.33% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OPRX FAQ
What was OptimizeRx Corporation’s price range in the past 12 months?
OptimizeRx Corporation lowest stock price was $3.78 and its highest was $16.64 in the past 12 months.
What is OptimizeRx Corporation’s market cap?
OptimizeRx Corporation’s market cap is $100.03M.
When is OptimizeRx Corporation’s upcoming earnings report date?
OptimizeRx Corporation’s upcoming earnings report date is Feb 26, 2025 which is in 27 days.
How were OptimizeRx Corporation’s earnings last quarter?
OptimizeRx Corporation released its earnings results on Nov 13, 2024. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.059 by $0.061.
Is OptimizeRx Corporation overvalued?
According to Wall Street analysts OptimizeRx Corporation’s price is currently Undervalued.
Does OptimizeRx Corporation pay dividends?
OptimizeRx Corporation does not currently pay dividends.
What is OptimizeRx Corporation’s EPS estimate?
OptimizeRx Corporation’s EPS estimate is 0.27.
How many shares outstanding does OptimizeRx Corporation have?
OptimizeRx Corporation has 18,420,906 shares outstanding.
What happened to OptimizeRx Corporation’s price movement after its last earnings report?
OptimizeRx Corporation reported an EPS of $0.12 in its last earnings report, beating expectations of $0.059. Following the earnings report the stock price went down -33.984%.
Which hedge fund is a major shareholder of OptimizeRx Corporation?
Among the largest hedge funds holding OptimizeRx Corporation’s share is S Squared Technology, LLC. It holds OptimizeRx Corporation’s shares valued at 0.
---
OptimizeRx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.06 (60.07% Upside)
$9.06 (60.07% Upside)
Blogger Sentiment
Bullish
OPRX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 17.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $100.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 4.3%
Last 30 Days ▲ 31.8%
Last 30 Days ▲ 31.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-63.53%
12-Months-Change
Fundamentals
Return on Equity
-20.97%
Trailing 12-Months
Asset Growth
33.30%
Trailing 12-Months
Company Description
OptimizeRx Corporation
OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.
---
OPRX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed sentiment with strong year-over-year revenue growth and significant improvements in gross margin and EBITDA. However, the company faced challenges with a revenue shortfall, increased net loss, and a goodwill impairment charge. Positive developments in client engagement, DAAP integration, and pipeline growth were highlighted, but the transition in the DTC business posed challenges.Read More>---
OPRX Stock 12 Month Forecast
Average Price Target
$9.06
▲(60.07% Upside)
Technical Analysis
Best Analysts Covering OPRX
1 Year
1 Year Success Rate
7/15 ratings generated profit
1 Year Average Return
+29.27%
reiterated a buy rating 3 months ago
Copying Richard Baldry's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of +29.27% per trade.
---